Remarkable science. Measurable results.
A curated collection of landmark positive human clinical trials in peptide medicine. We highlight the most promising outcomes while keeping each finding tied to its studied population.
Read the full clinical trials reportFour trials that moved the field.
Controlled clinical studies provide a clearer picture than anecdote. These figures are from the original published trials and should not be compared as head-to-head treatment rankings.
Semaglutide and weight management
Mean weight reduction at 68 weeks versus 2.4% with placebo. 1,961 participants.
Published studyTirzepatide at the studied highest dose
Mean weight reduction at 72 weeks versus 3.1% with placebo. 2,539 participants.
Published studyRelative reduction in major cardiovascular events
A risk reduction measured in a specific study group with established cardiovascular disease.
Published studyRelative reduction in the primary composite outcome
Trial focused on people living with type 2 diabetes and chronic kidney disease.
Published studyThis selection highlights favorable results, not every peptide trial. Reported benefits are not guarantees for individuals. All studies require review of adverse events, contraindications, participant selection and limitations.
Inside the clinical trials changing peptide medicine.
Explore the design, results and practical meaning of four landmark studies, with links to original published research.
Read the full report